The role of the endocannabinoid system in eating disorders: pharmacological implications

@article{Marco2012TheRO,
  title={The role of the endocannabinoid system in eating disorders: pharmacological implications},
  author={Eva M. Marco and Silvana Yanina Romero-Zerbo and Maria-Paz Viveros and Francisco Javier Berm{\'u}dez-Silva},
  journal={Behavioural Pharmacology},
  year={2012},
  volume={23},
  pages={526–536}
}
The endocannabinoid (eCB) system is a widespread intercellular signalling mechanism that plays a critical role in body homoeostasis. It is located in key points involved in food intake and energy expenditure, coordinating all the players involved in energy balance. As such, it has come to be seen as an interesting target for the management of diseases characterized by an imbalanced energy homoeostasis, such as obesity and eating disorders. The aetiology of eating disorders and the molecular… 

What Role Does the Endocannabinoid System Play in the Pathogenesis of Obesity?

TLDR
The role of the ECS and the impact of genetic factors on endocannabinoid system modulation in the pathogenesis of obesity is explained and the search for potential new targets for health assessment, treatment, and the development of possible therapies in obesity is emphasized.

The endocannabinoid system and appetite: relevance for food reward

TLDR
A better understanding of the role of the ECS in the rewarding value of specific foods or diets could offer new possibilities to optimise the balance between energy and nutrient intake for different target groups.

The Role of Endocannabinoids System in Fatty Liver Disease and Therapeutic Potentials

  • K. Alswat
  • Medicine, Biology
    Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association
  • 2013
TLDR
The pharmacological modulation of the EC system activity for the treatment of metabolic syndrome and NAFLD are promising yet premature, and the initial limited success due to deleterious central nervous system side-effects are likely to be bypassed with the use of peripherally restricted drugs.

The Endocannabinoid System: A Dynamic Signalling System at the Crossroads Between Metabolism and Disease

TLDR
It has become clear that the complexity of what may be called the “endocannabinoidome” demands for pharmacological approaches that take into account these dynamics, and chances for success are more likely to come from “multiple-target” than from "single-target" approaches.

Endocannabinoid signaling and food addiction

O Sistema Endocanabinóide - uma perspetiva terapêutica The Endocannabinoid system - a therapeutic perspective

TLDR
The potential role of (endo)cannabinoid system in therapeutics and the recent designed strategies for the development of drugs that target this system are reviewed.

Endocannabinoid Signaling in Reward and Addiction: From Homeostasis to Pathology

TLDR
This chapter discusses the influence of endocannabinoid signaling on the rewarding and motivational effects of natural rewards such as food, sex, and social interaction, as well as evidence demonstrating an endoc cannabinoidoid influence in the rewarding effects of abused drugs.

Cannabinoid Receptors: An Update on Cell Signaling, Pathophysiological Roles and Therapeutic Opportunities in Neurological, Cardiovascular, and Inflammatory Diseases

TLDR
An updated review of pre-clinical and clinical studies, the adequacy/inadequacy of cannabinoid-based therapeutics in various pathological conditions is highlighted, and alternative strategies to modulate endocannabinoid tone, and future directions are emphasized.

References

SHOWING 1-10 OF 114 REFERENCES

The role of the endocannabinoid system in the neuroendocrine regulation of energy balance

TLDR
A perspective on new promising strategies to selectively target the ECS in the context of energy balance regulation is given and new evidence suggests that peripherally restricted CB1 antagonists might be efficacious for the treatment of obesity and its associated metabolic disorders.

The endocannabinoid system and its relevance for nutrition.

TLDR
The main features of the ECS are summarized in order to put in better focus current knowledge of the nutritional relevance of endocannabinoid signaling and of its role in obesity, cardiovascular pathologies, and gastrointestinal diseases.

The endocannabinoid system: its roles in energy balance and potential as a target for obesity treatment.

The endocannabinoid system, eating behavior and energy homeostasis: The end or a new beginning?

The endocannabinoid system as a link between homoeostatic and hedonic pathways involved in energy balance regulation

TLDR
Bi-directional communications between the ECS and other key players in energy balance ensure local mediators such as the endocannabinoids to act in a way coordinated in both ‘space’ and ‘time’ to enhance food intake, particularly after a few hours of food deprivation.

Role of endocannabinoids and their analogues in obesity and eating disorders

TLDR
The pathophysiological significance of OEA in the regulation of eating and body weight is further evidenced by preliminary clinical results, showing altered levels of this molecule in the cerebrospinal fluid and plasma of subjects recovered from eating disorders.

Endocannabinoids and the control of energy balance

Minireview: Endocannabinoids and their receptors as targets for obesity therapy.

TLDR
The endocannabinoid system is hyperactive in obese humans and animals, and treating them with CB1 antagonists causes weight loss and improved lipid and glucose profiles.

The emerging role of the endocannabinoid system in endocrine regulation and energy balance.

TLDR
The ability of the endocannabinoid system to control appetite, food intake, and energy balance has recently received great attention, particularly in the light of the different modes of action underlying these functions.

Blood Levels of the Endocannabinoid Anandamide are Increased in Anorexia Nervosa and in Binge-Eating Disorder, but not in Bulimia Nervosa

TLDR
Findings show for the first time a derangement in the production of the endogenous cannabinoid AEA in drug-free symptomatic women with anorexia nervosa or with binge-eating disorder, which suggests a possible involvement of AEE in the mediation of the rewarding aspects of the aberrant eating behaviors occurring in AN and BED.
...